Sign In
Section Navigation
Common TitleAPOLLO
Official Title Enfuvirtide for the Initial Phase of Antiretroviral Therapy in HIV-infected Patients With High Risk of Clinical Progression : ANRS 130 APOLLO
Phase Phase III
ClinicalTrials.gov NCT00302822
Treatments
Enfuvirtide
Enfuvirtide Fuzeon

Enfuvirtide

Tradename:FuzeonOther Names:T-20Class:Entry Inhibitors
Categories Treatment-Naive
Funding
Non-IndustryFrench National Agency for Research on AIDS and Viral Hepatitis
References
  • Charpentier C, Joly V, Larrouy L, et al. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial. J Antimicrob Chemother. 2013;68:690-6.
    [PubMed Abstract]
  • Joly V, Fagard C, Grondin C, et al. Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo). Antimicrob Agents Chemother. 2013;57:758-65.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.